• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Calloway Laboratories

Anonymous board for Calloway Laboratories
Replies
7
Views
9K
anonymous
Replies
83
Views
37K
anonymous
Replies
0
Views
3K
anonymous
Replies
1
Views
2K
anonymous
Replies
29
Views
19K
anonymous
Replies
2
Views
2K
anonymous
Replies
2
Views
2K
anonymous
Replies
2
Views
4K
anonymous
Replies
0
Views
2K
anonymous
Replies
0
Views
2K
Anonymous
Replies
7
Views
6K
Anonymous
Replies
0
Views
2K
Anonymous
Replies
0
Views
3K
Anonymous
Replies
1
Views
4K
Anonymous
Replies
1
Views
4K
Anonymous
Replies
36
Views
29K
Anonymous
Replies
1
Views
6K
Anonymous